ArticleBMC cancer2026

A phase 1b open-label, dose-escalating study of safety and efficacy of disulfiram, copper and vinorelbine in advanced solid tumors.

Rikke Løvendahl Eefsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.